
zzso zzso prevents the zzso of maximum achievable peak bone mass in zzso In zzso zzso suppresses zzso and zzso zzso zzso through induction of zzso zzso pharmacological suppression of zzso zzso zzso differentiation and zzso in zzso 

zzso is a major health zzso Traditional therapeutic strategies have centered on zzso drugs that block bone zzso Recently focus has shifted to anabolic agents that actively rebuild lost bone zzso Future strategies may involve zzso peak bone mass to delay osteoporosis zzso Recent in zzso studies show that zzso zzso zzso differentiation and zzso however, the mechanisms are poorly understood and the impact of zzso zzso zzso on the acquisition of peak bone mass in zzso is zzso 

We examined peak zzso bone volume, and bone turnover makers in mice deficient in zzso or its zzso We further examined the effect of zzso on zzso signaling by zzso and zzso in zzso using a zzso responsive zzso The effect of zzso zzso signaling on zzso signaling and on in zzso zzso zzso was examined using specific zzso zzso and zzso and effects of zzso zzso signaling on zzso zzso zzso were examined using zzso 

Mice zzso for zzso or its zzso zzso had significantly increased peak bone mass, resulting exclusively from elevated bone zzso In zzso zzso zzso suppressed zzso signaling induced by zzso and zzso zzso zzso zzso zzso and inhibited zzso of zzso These effects were zzso by zzso of zzso and prevented by pharmacological zzso zzso 

Our data suggest that zzso and zzso zzso may represent novel anabolic agents for the zzso of peak zzso bone mass and/or the zzso of pathological bone zzso 

